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Radiation is one of the most effective cancer treat-
ments. However, gastrointestinal (GI) syndrome is
a major limiting factor in abdominal and pelvic radio-
therapy. The loss of crypt stem cells or villus endo-
thelial cells has been suggested to be responsible
for radiation-induced intestinal damage. We report
here a critical role of the BH3-only protein p53 upre-
gulated modulator of apoptosis (PUMA) in the radio-
sensitivity of intestinal epithelium and pathogenesis
of GI syndrome. PUMA was induced in a p53-depen-
dent manner and mediated radiation-induced apo-
ptosis via the mitochondrial pathway in the intestinal
mucosa. PUMA-deficient mice exhibited blocked
apoptosis in the intestinal progenitor and stem cells,
enhanced crypt proliferation and regeneration, and
prolonged survival following lethal doses of radia-
tion. Unexpectedly, PUMA deficiency had little effect
on radiation-induced intestinal endothelial apopto-
sis. Suppressing PUMA expression by antisense oli-
gonucleotides provided significant intestinal radio-
protection. Therefore, PUMA-mediated apoptosis in
the progenitor and stem cell compartments is crucial
for radiation-induced intestinal damage.
INTRODUCTION
Gastrointestinal toxicity is the primary limiting factor in abdomi-
nal and pelvic radiotherapy. Mice that receive greater than 14
Gray (Gy) die between 7 and 12 days due to damage to the small
intestine and complications known as gastrointestinal (GI) syn-
drome (Komarova et al., 2004; Potten, 2004). The molecular de-
terminants of intestinal radiosensitivity and GI syndrome are not
well understood. Some believe that damage to stem cells plays
a critical role in this process (Ch’ang et al., 2005; Potten, 2004).
However, their precise location and characteristics had been
elusive due to lack of definitive molecular markers. Many earlier
studies suggested that putative stem cells reside at the cell po-
sition 4–6 immediately above Paneth cells (Giannakis et al.,576 Cell Stem Cell 2, 576–583, June 2008 ª2008 Elsevier Inc.2006; Potten, 2004; Stappenbeck et al., 2003). However, re-
cently, genetic evidence convincingly showed that the columnar
cells at crypt base (CBCs) that intermingled with Paneth cells are
intestinal stem cells and suggest the cells at position 4–6 as pro-
genitor cells (Barker et al., 2007). Several pathways have been
implicated in regulating radiation-induced apoptosis in the crypt
cells, including those of the tumor suppressors p53 and ATM
(Ch’ang et al., 2005). p53 deficiency blocks early apoptosis in
the crypt, occurring 3–6 hr following radiation, but leads to accel-
erated GI syndrome and animal death (Komarova et al., 2004;
Merritt et al., 1994). The key mediator of p53-dependent apopto-
sis in this system has yet to be identified despite a long list of
possible candidates (Potten, 2004; Yu and Zhang, 2005).
Others believe that endothelial apoptosis, which is indepen-
dent of p53, is involved in the pathogenesis of GI syndrome,
and suggest that the radiation-targeted cells switch from endo-
thelial cells to epithelial cells at higher doses of radiation (Ch’ang
et al., 2005; Paris et al., 2001). In this model, acid sphingomyeli-
nase (ASMase)-mediated ceramide production was suggested
to be responsible for apoptosis either in endothelial cells (lower
than 18 Gy) or epithelial cells (higher than 18 Gy). Systemic
administration of basic fibroblast growth factor, capable of
suppressing ASMase in the endothelial cells, or deficiency in
ASMase protected the murine small intestine from radiation-
induced damage (Ch’ang et al., 2005; Paris et al., 2001).
We and others identified PUMA (p53 upregulated modulator of
apoptosis) as a BH3-only Bcl-2 family protein that plays an
essential role in p53-dependent and -independent apoptosis
(Yu et al., 2001; Nakano and Vousden, 2001; Han et al., 2001).
PUMA deficiency blocks apoptotic responses to p53 activation,
DNA-damaging agents, and hypoxia in various tissue and cell
types, including human cancer cells, mouse thymocytes, embry-
onic fibroblasts (MEFs), hematopoietic cells, and developing
neurons (Yu et al., 2003; Jeffers et al., 2003; Villunger et al.,
2003; Erlacher et al., 2005). Upon transcriptional induction in re-
sponse to DNA damage, PUMA functions through other Bcl-2
family members, including Bax, Bcl-2, and Bcl-xL, to induce mi-
tochondrial dysfunction and caspase activation (Yu et al., 2003,
2007; Ming et al., 2006; Wang et al., 2007).
In this study, we report a critical role for PUMA-mediated
apoptosis in the radiosensitivity of intestinal progenitor and
stem cell compartments and the pathogenesis of GI syndrome.
We found that p53-dependent PUMA induction is largely
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genitor and stem cells. PUMA deficiency resulted in enhanced
crypt regeneration and prolonged survival of mice following
lethal doses of radiation. Despite a rapid induction of PUMA by
radiation in the intestinal endothelial cells, its ablation had virtu-
ally no effect on their apoptosis. Our data suggest that targeting
PUMA may be therapeutically useful to manipulate the radiation
responses in cancer patients.
RESULTS
Radiation Rapidly Induced Intestinal PUMA Expression
PUMA expression in the intestinal mucosa of wild-type (WT)
mice was examined by real-time RT-PCR and western blotting.
PUMA mRNA was induced by 4-, 9-, and 7-fold at 4 hr after 8,
15, and 18 Gy of whole-body radiation (WBR), respectively
(Figure 1A). The induction decreased by more than 60% by
24 hr and almost disappeared by 48 hr (Figure 1A; data not
shown). PUMA protein expression was elevated at 4 hr and con-
tinued to increase at 24 hr (Figure 1B). RNA in situ hybridization
(ISH) indicated strong staining of PUMA mRNA in the crypts 4 hr
after 18 Gy radiation, which decreased significantly at 24 hr
(Figure 1C). PUMA staining was primarily localized to the lower
part of the crypt, both in the cells at positions 4–6 (Figures 1C
and D) and in the columnar cells at crypt base (CBCs)
(Figure 1E and Figure S1A). The CBCs stained positive for the
proliferation marker Ki-67 but negative for Paneth cell marker
cryptdin 4 or MMP-7 (Barker et al., 2007). We also noticed that
some +4 cells appear intermingled with Paneth cells (Figure 1E
and Figure S1A). Similar results were obtained from mice
Figure 1. Radiation Induced Intestinal PUMA Expression
(A) PUMA mRNA expression in the jejunal mucosa of mice follow-
ing whole body radiation (WRB) was evaluated by quantitative
real-time RT-PCR. Values are means ± SD; n = 3 in each group.
*p < 0.01; **p < 0.001.
(B) PUMA, p53, and p21 protein expression in the jejunal mucosa
of mice with indicated genotypes was determined by western
blotting. b-actin was used as the control for loading.
(C) PUMA mRNA in situ hybridization (ISH) in the jejunum of mice
following radiation (magnification 3400). The selected area is
shown at a higher magnification. Arrows indicate examples of
PUMA-expressing cells.
(D) PUMA mRNA expression (ISH) in the crypts was scored ac-
cording to the cell position, pooled from 2 mice in each group.
(E) PUMA expression in the columnar cells at the crypt base
(CBCs) at 4 hr after 18 Gy. Examples of the CBCs are circled in
red and stained positive for Ki-67 but negative for Paneth cell
markers cryptdin 4 and MMP-7, magnification 3600.
received 15 Gy WBR (data not shown). These results
indicate that radiation rapidly induced PUMA mRNA
and protein expression in the progenitor and stem
cell compartments of the small intestine.
PUMA Deficiency Impaired Radiation-Induced
Apoptosis in the Intestinal Progenitor
and Stem Cells
Radiation (18 Gy) induced marked apoptosis in the
crypt of WT mice, which was blocked by 90% and
80% at 4 and 24 hr in PUMA KO mice, respectively (Figures 2A
and 2B). The DNA laddering in the intestinal mucosa and apopto-
sis of villus epithelial cells were also significantly suppressed in
PUMA KO mice (Figures S1B and S1C). More specifically, apo-
ptosis at the cell positions 4–6 was blocked by 92% and 66%
in PUMA KO mice at 4 and 24 hr, respectively (Figures 2C and
2D). Notably, in WT animals, PUMAmRNA was highly expressed
in the apoptotic cells identified by the putative progenitor marker
Musashi (Figures 2E and 2F) (He et al., 2007; Potten et al., 2003).
The putative progenitor cells in WT mice are highly sensitive to
radiation-induced apoptosis, and more than 95% crypts con-
tained apoptotic cells at positions 4–9 following 8, 15, or 18 Gy
(Figure 2A; Figures S2B and S3B). In contrast, the CBCs are
more resistant to radiation-induced apoptosis (Barker et al.,
2007), with the fraction of crypts containing apoptotic CBCs at
10%, 27.5%, and 35% after 8, 15, and 18 Gy in WT mice, respec-
tively (Figures 2G and 2H). PUMA deficiency also blocked apo-
ptosis in the CBCs by at least 50% at 4 and 24 hr (Figure 2H).
These results demonstrate that PUMA is an important mediator
of radiation-induced apoptosis in the intestinal progenitor and
stem cells.
PUMA Deficiency Did Not Affect Radiation-Induced
Intestinal Endothelial Apoptosis
Several groups suggested the involvement of endothelial apo-
ptosis in the pathogenesis of GI syndrome (Ch’ang et al., 2005;
Paris et al., 2001). However, we found that radiation-induced ap-
optosis in the lamina propria of WT mice occurred to a similar de-
gree at 4 hr following different doses of radiation (8, 15, and 18 Gy)
and consistently decreased by over 80% at 24 hr (Figures 3ACell Stem Cell 2, 576–583, June 2008 ª2008 Elsevier Inc. 577
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Apoptosis in the Intestinal Progenitor and
Stem Cells
(A) Apoptosis in the small intestinal crypts at 4 hr
and 24 hr after 18 Gy WBR was assessed by
TUNEL staining (brown), magnification 3400.
(B) Apoptotic index in the crypts measured by
TUNEL staining. Values are means ± SD; n = 3 in
each group. *p < 0.005.
(C) Example of apoptotic cells and their position in
the crypt at 4 hr following 18 Gy WBR, magnifica-
tion31000. Paneth cells are indicated with arrow-
heads while non-Paneth cells are indicated by
arrows.
(D) Apoptotic index at 4 hr (left panel) and 24 hr
(right panel) following radiation. The apoptotic in-
dex was scored as the mean percentage of apo-
ptotic cells of each cell position, pooled from
four mice in each group.
(E) PUMA ISH, and PUMA ISH/TUNEL double
staining in the crypts 4 hr after 15 Gy, magnifica-
tion 3400. Arrows indicate double-positive cells.
(F) Serial sections (WT mice, 15 Gy at 4 hr) were
subjected to TUNEL staining and Musashi IHC,
magnification 31000. Arrows indicate positive
signals.
(G) Radiation-induced apoptosis in the CBCs.
Sections were stained with TUNEL or TUNEL fol-
lowed by MMP-7 IHC with several CBCs circled,
magnification 3600.
(H) The fractions of crypts with at least one
TUNEL-positive CBCs were calculated by count-
ing 100 crypts with well preserved Paneth cell
areas. Values are means ± SD; n = 3 in each group.
*p < 0.005.and 3B). Unexpectedly, apoptosis in this compartment was not
affected in PUMA KO mice, despite a rapid and robust induction
of PUMA by 4 hr in WT mice (Figure 3C and data not shown).
Using an endothelial marker CD105 (endogolin; Ge and Butcher,
1994), we found that only a small percentage (less than 14%) of
CD105-positive cells underwent apoptosis 4 hr after 18 or
15 Gy radiation, which decreased to less than 5% at 24 hr (Fig-
ures 3D–3F). Furthermore, neither the fraction of apoptotic
CD105-positive cells nor the total number of CD105-positive
cells following radiation was affected in PUMA KO mice (Figures
3F and G). The majority of apoptotic endothelial cells expressed
PUMA (Figure 3J; Figures S4B and S4C). Apoptosis in the endo-
thelial cells occurred soon (within 1 hr) after radiation (Figure 3H;
Figure S4A) and led to an apparent reduction (30%–50%) in their
numbers within 4 hr (Figures 3G and I). In addition, PUMA induc-
tion was more limited in other cell types, such as hematopoietic
cells (19% of cells), compared with that in the endothelial cells
(80%–85% of cells) (Figure S4D). The above data suggest that
PUMA is rapidly and widely induced in the endothelial compart-
ment of the small intestine following radiation but is not required
for its apoptosis.
Radiation-Induced Intestinal Apoptosis Is Mediated
through the Mitochondrial Pathway
To investigate the mechanisms of PUMA-mediated apoptosis fol-
lowing radiation, we analyzed several mitochondria-related events578 Cell Stem Cell 2, 576–583, June 2008 ª2008 Elsevier Inc.in the intestinal mucosa. Radiation induced cytosolic release of
cytochrome c, mitochondrial translocation, and multimerization of
Bax in WT mice, which were virtually blocked in PUMA KO mice
(Figures 4A and 4B). As Bax and Bak have redundant functions in
some cells (Zong et al., 2001), we also examined Bak translocation
and multimerization. Bak multimerization was slightly reduced in the
irradiated PUMA KO mice, while no change in Bak redistribution
was detected (Figures 4A and 4B). Nevertheless, radiation-induced
caspase 3 activities and processing were significantly blocked in
PUMA KO mice (Figures 4C and D). Consistent with a role of Bax
in PUMA-mediated apoptosis, BAX KO mice exhibited reduced
crypt apoptosis (Figure 4E). These results collectively suggest that
PUMA mediates radiation-induced intestinal apoptosis predomi-
nantly through Bax activation and the mitochondrial pathway.
PUMA Deficiency Resulted in Enhanced Crypt
Regeneration and Prolonged Survival
of Mice Following WBR
We reasoned that enhanced stem or progenitor cell survival in
PUMA KO mice would lead to enhanced crypt proliferation and
regeneration following radiation. Comparison of proliferation in
the small intestine of WT and PUMA KO mice revealed no signif-
icant difference before or 4 hr after 18 Gy. However, there were
twice as many BrdU-positive cells at 24 hr in PUMA KO mice
(Figure 5A; Figure S5A). Microcolony assay was used to measure
the regeneration capacity of stem cells at day 4 after 15 Gy
Cell Stem Cell
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Radiation-Induced Intestinal Endothelial
Apoptosis
(A) Apoptosis induced by radiation in the villus was
assessed by TUNEL staining (brown), magnifica-
tion 3400.
(B) Apoptotic index in the villus submucosa.
Values are means ± SD. n = 3 mice in each group.
(C) PUMA mRNA (red) ISH in the jejunal villi, mag-
nification 3200.
(D and E) The sections were double stained with
TUNEL (brown) and CD105 (blue), magnifications
3200 and 31000, respectively. Arrows indicate
double positive cells.
(F) The average fraction (%) of TUNEL+/CD105+
cells in the villus. Values are means ± SD; n = 3
mice in each group.
(G) The average number of CD105+ cells in the vil-
lus. Values are means ± SD; n = 3 mice in each
group.
(H) Apoptotic index of CD105+ cells was deter-
mined at indicated times in WT and PUMA KO
mice as in (F).
(I) The number of CD105+ cells were determined at
indicated times as in (G).
(J) Apoptotic index of CD105+/PUMA+ cells in WT
mice and that of CD105+ cells in PUMA KO mice
were determined in 100 villi/mouse. Values are
means ± SD; n = 3 mice in each group.radiation. We found that crypt regeneration increased by nearly
100% in PUMA KO mice compared with that in WT mice
(Figure 5B; Figure S5B). Crypt regeneration was also enhanced
in BAX KO mice, though to a lesser extent than that in PUMA
KO mice (Figure 5C). Since almost all crypts vanished at day 3
(Figure S5C), the crypts found on day 4 are likely to be formed
‘‘de novo’’ by radio-resistant stem cells (i.e., CBCs), which are
devoid of Musashi expression (Figure S6). The intestinal epithe-
lium completely recovered in both WT and PUMA KO mice at
a lower dose of radiation (8 Gy) (Figure S7).
We then determined whether differences in crypt apoptosis
and regeneration have an impact on animal survival. PUMA KO
mice were found to survive approximately 50% longer than their
wild-type counterparts after 15 Gy or 18 Gy WBR (Figure 5D).
Drastic differences in the degree of intestinal injury were revealed
by histological analysis (Figure 5E). A progressive reduction in
the length of villi, culminating in their complete destruction,
was evident in WT mice from 72 to 108 hr. Massive lymphocytic
infiltration and thickening of the lamina propria below the base of
the crypts suggested loss of intestinal epithelial integrity. How-
ever, the villus shortening and submucosal inflammation were
significantly blunted in PUMA KO mice (Figure 5E). This probably
explains why more than 80% of wild-type mice had died while
100% of PUMA KO mice were alive by 108 hr following 18 Gy
WBR (Figure 5D). These data suggest that PUMA plays a critical
role in the development of GI syndrome and the death of clono-
genic stem cells following lethal doses of radiation.
p53 and Radiation-Induced Intestinal PUMA Expression
We then sought to determine whether p53 plays a role in radia-
tion-mediated PUMA induction in the intestinal mucosa. The in-duction of PUMAmRNA and protein was found to be completely
abrogated in p53 KO mice (Figures 6A and 6B). Compared with
WT mice, crypt apoptosis was reduced by 40% and 60% in p53
KO mice at 4 and 24 hr following radiation, respectively
(Figure 6C; Figure S8A). The early crypt apoptosis induced by
8 Gy radiation was blocked to a similar extent in p53 KO and
PUMA KO mice (Figures S9 and S3). In contrast to PUMA KO
mice, p53 KO mice exhibited a profound increase (2.3-fold) in
crypt proliferation by 24 hr (Figures S8B and S8C) but only a slight
increase in crypt regeneration with almost complete destruction
of villi by 96 hr (Figure 6D; Figure S8D). Consistent with these
pathological findings, p53 KO mice died 3.5 days sooner than
WT mice on average (Figure 5D; data not shown). Radiation
can induce p53-independent apoptosis in some cells (Strasser
et al., 1994). We therefore examined the expression of several
other BH3-only proteins, including Bid, Bad, and Bim. Interest-
ingly, none were induced by radiation in p53 KO mice, while
Bid and Bad were induced in WT mice (Figure S8E). These
data suggest that p53-dependent PUMA induction is a key de-
terminant of GI syndrome, and proteins other than the proapop-
totic Bcl-2 members might contribute to the exacerbated GI syn-
drome found in p53 KO mice.
PUMA Antisense Oligonucleotides Suppressed
Intestinal Apoptosis and Prolonged Survival
of Mice Following WBR
Theabovedata imply thatmanipulationofPUMAexpression is likely
to provide intestinal radioprotection. To test this hypothesis, we first
identified several PUMA antisense oligonucleotides (PUMA AS2
and AS3) that efficiently inhibited PUMA expression induced by
Brefeldin A, an inhibitor of intracellular protein transport, in MEFsCell Stem Cell 2, 576–583, June 2008 ª2008 Elsevier Inc. 579
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a sense oligo, markedly inhibited intestinal PUMA expression in-
duced by radiation and led to reduced crypt apoptosis, enhanced
crypt proliferation, and regeneration (Figures 7B–7E; Figures
S10A–S10D). The PUMA antisense oligos also increased the LD50
(number of days required to kill 50% of the animals) from 7 to
9 days (Figure 7F). These data indicate that PUMA inhibition pro-
vides significant intestinal radioprotection and prolongs survival.
DISCUSSION
The underlying molecular mechanisms of radiation-induced GI
toxicity are largely unknown (Gudkov and Komarova, 2003;
Komarova et al., 2004; Potten, 2004) despite their important
implications in improving cancer treatment. In the current study,
we showed that the BH3-only protein PUMA is a critical mediator
of intestinal apoptosis induced by radiation predominantly via
modulation of Bax activities. p53-dependent PUMA induction
is mainly, if not solely, responsible for radiation-induced and
p53-dependent early apoptosis in the intestinal progenitor cells.
PUMA deficiency delayed GI syndrome and prolonged the sur-
vival of mice following lethal doses of radiation. To our knowl-
edge, this is the first report in which deficiency in a single gene
significantly protects against GI syndrome by preserving the pro-
genitor and stem cell compartments and the structure and integ-
rity of intestinal epithelium. The CBCs seem more resistant to the
induction of apoptosis and PUMA following radiation compared
Figure 4. PUMA Mediated Radiation-Induced Intestinal Apoptosis
via the Mitochondrial Pathway
(A) Bax, Bak, and cytochrome c (Cyto c) were analyzed in the cytosolic and mi-
tochondrial fractions of intestinal mucosa by western blotting. b-actin and
CoxIV were used as the controls for loading and fractionation.
(B) Formation of Bax and Bak multimers was analyzed in the chemical cross-
linker DSP-treated mitochondrial fractions by western blotting under nondena-
turing conditions.
(C) Caspase 3 activity was measured in the intestinal mucosa extracts. Values
are means ± SD; n = 6 mice in each group. *p < 0.01.
(D) Caspase 3 processing and b-actin levels were analyzed by western blot-
ting. Results of two representative animals from the treated groups are shown.
(E) Apoptotic index in the crypt was quantitated in WT and BAX KO mice after
15 Gy as in Figure 2B. Values are means ± SD; n = 3 mice in each group.
W, WT mice; K, PUMA KO mice.580 Cell Stem Cell 2, 576–583, June 2008 ª2008 Elsevier Inc.with the cells at position 4–6 (Figures 1 and 2; Figures S1–S3).
However, it is important to realize that our ability to detect the
CBCs is still limited due to the fact that these long and slender
cells are in close proximity to Paneth cells that are much more
visually prominent. Therefore, the extent of apoptosis and
PUMA expression in the CBCs might actually be higher. With
the aid of a recently described intestinal stem cell marker and
mouse models (Barker et al., 2007), future lineage tracing exper-
iment should provide more definitive answers as to the genes
and cellular compartment(s) involved in GI syndrome and crypt
regeneration following radiation.
Our findings have several important implications. They provide
a mechanistic explanation of intestinal radiosensitivity. Our study
showed that PUMA was rapidly induced in both the progenitor
and stem cell compartments in the small intestine and its abla-
tion largely prevented their apoptosis within 24 hr (Figures 1
and 2; Figures S1–S3). PUMA ablation enhanced crypt prolifera-
tion and regeneration and preserved the intestinal integrity in
a later phase (Figure 5). PUMA ablation had little effect on radia-
tion-induced endothelial apoptosis despite its rapid induction in
WT mice (Figure 3). Therefore, epithelial apoptosis, but not endo-
thelial apoptosis, is the primary lesion in the rapid phase of radi-
ation-induced intestinal damage as suggested by others (Hendry
et al., 2001; Suit and Withers, 2001). Furthermore, our data fail to
support the target switching model (Ch’ang et al., 2005; Paris
et al., 2001), as endothelial apoptosis rapidly declined within
24 hr and was not affected by the doses of radiation (Figure 3).
The discrepancy between our findings and those (Ch’ang
et al., 2005; Paris et al., 2001) might be explained by the differ-
ences in the strains of mice and/or the doses of radiation and
methods of detecting endothelial cells. It is possible that endo-
thelial and epithelial apoptosis contribute to different aspects
of GI death-associated syndrome, and the use of PUMA and
ASMase double knockout mice might provide an answer.
The different responses of PUMA and p53-deficient mice pro-
vide an explanation for a seemingly paradoxical role of p53 in
intestinal radiosensitivity. Our data strongly argue that PUMA is
the primary, if not sole, mediator of p53-dependent apoptosis
among all the proapoptotic p53 targets in the small intestine in re-
sponse to radiation (Figures 1, 2, and 6) (Yu and Zhang, 2005). p53
and p21 deficiencies have been reported to accelerate GI syn-
drome and animal death (Komarova et al., 2004). It appears that
p53-mediated p21 induction protects against GI syndrome while
p53-mediated PUMA induction promotes GI syndrome (Figures 5
and 6). Interestingly, p21 levels were found to be significantly
higher in the intestinal mucosa of PUMA KO mice after radiation
(Figure 1B). One explanation is that p21-mediated cell-cycle ar-
rest followed by DNA repair in the stem cell compartment is nec-
essary for multiple rounds of successful cell division and ultimately
crypt regeneration (Figures 5A and 5B). Therefore, it might be in-
teresting to determine the intestinal radiosenstivity of mice defi-
cient in both PUMA and p21. We would predict an even greater
proliferative response, but less crypt regeneration following radi-
ation in the double knockout mice than in PUMA KO mice. Future
work is clearly needed to understand how cell death and prolifer-
ation are coordinated to regulate the intestinal stem cell regener-
ation following DNA damage or other clinically relevant insults.
Lastly, our data provides a rationale to target PUMA in GI syn-
drome. Several growth factors, including insulin growth factor
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fibroblast growth factor-2 (FGF-2), have been shown to protect
crypt progenitor cells and increase animal survival following
WBR, but their targets have not been identified (Booth and
Potten, 2001). IGF-1, epidermal growth factor (EGF), and serum
can suppress PUMA expression independent of p53 (Han et al.,
2001; L.H. Ming, T. Sakaida, and J.Y, unpublished data). It is
possible that inhibiting PUMA expression is a common mecha-
nism underlying the radioprotective effects of these factors. If
so, it might be useful to identify small molecule PUMA inhibitors
with more desirable pharmacological properties. PUMA defi-
ciency potently protects hematopoietic progenitor cells and lym-
phocytes from p53-dependent radiation-induced apoptosis
(Erlacher et al., 2005; Wu et al., 2005). Since more than 50% of
human tumors are defective in p53 (Vogelstein et al., 2000), it
is expected that PUMA is not induced in these tumors following
radiotherapy. Therefore, selectively curbing radiosensitivity in
the normal tissues transiently by small molecule PUMA inhibitors
might be particularly beneficial in cancer therapy.
EXPERIMENTAL PROCEDURES
Mice and Ionizing Radiation
The procedures of all animal experiments were approved by the Institutional An-
imal Care and Use Committee (IACUC) at University of Pittsburgh. The original
PUMAKO mice on a mixed background (Jeffers et al., 2003) were backcrossed
to C57BL/6 for six generations (F6). Eight- to ten-week-old PUMA+/+ and
PUMA/ littermates were generated from F6 heterozygote breeding. C57BL/
6 p53/, Bax/, and control mice were purchased from Jackson Laboratory.
The mice were housed and genotypes as described (Wu et al., 2007). Mice were
irradiated at doses ranging from 0 to 18 Gy at a rate of 82 cGy/min using a 137Cs
irradiator (Mark I, J.L. Shepherd and Associates, San Fernando, CA).
Figure 5. PUMA Deficiency Prolonged the
Survival of Mice Following WBR
(A) BrdU incorporation index in the small intestine
was quantitated by counting 100 crypts. Values
are means ± SD; n = 3 mice in each group.
(B) Crypt regeneration was calculated by counting
10 cross-sections following BrdU staining. Values
are means ± SD; n = 4 in each group.
(C) Regenerated crypts were quantitated in WT
and BAX KO mice after 15 Gy WBR as in (B);
n = 3 in each group.
(D) Survival curves of mice subjected to 15 Gy or
18 Gy WBR.
(E) H&E staining of the small intestine sections,
magnification 3200.
RNA In Situ Hybridization
The protocol has been previously described
(Carson-Walter et al., 2005; St. Croix et al., 2000).
Digoxygenin-labeled PUMA antisense RNA
probes were generated by PCR amplification
with incorporation of a T7 promoter into the anti-
sense primer (Table S2).
Histological Analysis, TUNEL,
and BrdU Staining
All mice were injected with BrdU (100 mg/kg;
Sigma Chemical Co., St. Louis, MO) 2 hr prior to
sacrifice. Sections (5 mm) from paraffin-embedded
intestinal bundles were subjected to hematoxylin and eosin (H&E) staining for
histological analysis.
TUNEL staining was performed using an ApopTag Kit (Chemicon interna-
tional, Temecula, CA) according to the manufacturer’s instructions. The
apoptotic index was scored in full longitudinal sections of crypts containing
at least 17 cells, including Paneth cells. The frequency of apoptosis for each
cell position from the crypt bottom was scored in 200 half-crypt sections.
Following BrdU staining, the BrdU-positive cells in the crypt were scored
by counting 100 intact crypts. The data was reported as mean ± SEM. Three
or more mice were used in each group. More detail protocols were described
in the Supplemental Data.
Immunohistochemistry
The detailed methods for the staining of Musushi, Ki67, cryptdin 4, MMP-7,
and double staining of TUNEL/CD105, TUNEL/MMP-7, PUMA ISH/TUNEL,
PUMA ISH/MMP-7, PUMA ISH/CD105, and PUMA ISH/CD45 are described
in the Supplemental Data.
Crypt Microcolony Assay
Stem cell survival was quantified by counting regenerated crypts in HE-stained
and BrdU-stained cross-sections 4 days after radiation as detailed in the Sup-
plemental Data. Four to five mice were used in each group, and the data were
reported as means ± SEM.
Caspase 3 Activity Assay
The assay was performed as described using the extract of intestinal mucosal
scraping, with the results expressed as absorbance at 405 nm per milligram
protein (Wu et al., 2007). Each experiment was performed in triplicate and
repeated at least twice. Six mice were used in each group.
Total RNA Extraction and Real-Time Reverse Transcriptase
Polymerase Chain Reaction
Total RNA was prepared from freshly scraped mucosa, and cDNA was then
generated for real-time PCR analysis of PUMA mRNA as described (Wu
et al., 2007). Three mice were used in each group.Cell Stem Cell 2, 576–583, June 2008 ª2008 Elsevier Inc. 581
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Total protein extract, mitochondrial, and cytosolic fractions were purified and
analyzed by NuPage gel (Invitrogen, Carlsbad, CA) electrophoresis as previ-
ously described (Kohli et al., 2004; Yu et al., 2003). The purified mitochondrial
fractions were crosslinked using 1 mM Dithiobis(succinimidyl)propionate
(DSP) (Pierce, Rockford, IL) to detect Bax or Bax multimerization as described
(Wu et al., 2007). Three mice were used in each experimental group unless
specified. The antibodies used were described in the Supplemental Data.
In Vitro and In Vivo Treatment with PUMA
Antisense Oligonucleotide
Phosphorothioated PUMA antisense oligonucleotides AS1, AS2, AS3, and
AS4 (Table S1) were synthesized by IDT (Coralville, IA). The MEFs (Sobol
et al., 2003) were cultured in DMEM (Invitrogen) supplemented with 10%
defined fetal bovine serum (Hyclone, Logan, UT), 100 units/ml penicillin and
100 mg/ml streptomycin (Invitrogen) The MEFs were treated with Brefeldin A
(Calbiochem, La Jolla, CA) for 48 hr to test the efficiency of PUMA antisense
oligos (12.5 mM). For in vivo studies, the mice were treated with PUMA sense
or PUMA antisense oligo at 25 mg/kg/day via intraperitoneal (i.p.) injection,
starting 2 days before WBR and continued until 4 days post-WBR. Seven to
ten animals were used in each group for the survival studies.
Statistical Analysis
Data were analyzed by unpaired t test or ANOVA in which multiple compari-
sons were performed using the method of least significant difference. The sur-
vival data was analyzed by log-rank test using GraphPad Prism 4 software.
Data in Figures 5A, 6D, and 7D were analyzed additionally by Mann-Whitney
test, with the largest p value depicted. Differences were considered significant
if the probability of the difference occurring by chance was less than 5 in 100
(p < 0.05).
Figure 6. PUMA Mediated p53-Dependent Crypt Cell Apoptosis
Induced by Radiation
(A) PUMA mRNA expression in the intestinal mucosa was evaluated by quan-
titative real-time RT-PCR. Values are means ± SD; n = 3 in each group.
*p < 0.001; **p < 0.01.
(B) PUMA, p21, p53, and b-actin protein expression in the intestinal mucosa
were determined by western blotting.
(C) Apoptotic index measured by TUNEL staining. Values are means ± SD, and
n = 3 in each group. *p < 0.01, **p < 0.001.
(D) Regenerated crypts were quantitated after 15 Gy WBR by counting
10 BrdU stained sections. Values are means ± SD; n = 4 in each group.582 Cell Stem Cell 2, 576–583, June 2008 ª2008 Elsevier Inc.SUPPLEMENTAL DATA
The Supplemental Data include two tables and ten figures and can be found
with this article online at http://www.cellstemcell.com/cgi/content/full/2/6/
576/DC1/.
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